Global and United States Vaccine Conjugate Market Report & Forecast 2024-2031

Report ID: 1838304 | Published Date: Sep 2024 | No. of Page: 91 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Vaccine Conjugate Product Introduction
    1.2 Global Vaccine Conjugate Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Vaccine Conjugate Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Vaccine Conjugate Sales in Volume for the Year 2017-2028
    1.3 United States Vaccine Conjugate Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Vaccine Conjugate Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Vaccine Conjugate Sales in Volume for the Year 2017-2028
    1.4 Vaccine Conjugate Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Vaccine Conjugate in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Vaccine Conjugate Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Vaccine Conjugate Market Dynamics
        1.5.1 Vaccine Conjugate Industry Trends
        1.5.2 Vaccine Conjugate Market Drivers
        1.5.3 Vaccine Conjugate Market Challenges
        1.5.4 Vaccine Conjugate Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Vaccine Conjugate Market Segment by Type
        2.1.1 Hib Vaccine
        2.1.2 Meningococcal Vaccine
        2.1.3 Pneumococcal Vaccine
        2.1.4 Others
    2.2 Global Vaccine Conjugate Market Size by Type
        2.2.1 Global Vaccine Conjugate Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Vaccine Conjugate Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Vaccine Conjugate Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Vaccine Conjugate Market Size by Type
        2.3.1 United States Vaccine Conjugate Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Vaccine Conjugate Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Vaccine Conjugate Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Vaccine Conjugate Market Segment by Application
        3.1.1 Children
        3.1.2 Adult
    3.2 Global Vaccine Conjugate Market Size by Application
        3.2.1 Global Vaccine Conjugate Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Vaccine Conjugate Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Vaccine Conjugate Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Vaccine Conjugate Market Size by Application
        3.3.1 United States Vaccine Conjugate Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Vaccine Conjugate Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Vaccine Conjugate Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Vaccine Conjugate Competitor Landscape by Company
    4.1 Global Vaccine Conjugate Market Size by Company
        4.1.1 Top Global Vaccine Conjugate Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Vaccine Conjugate Revenue by Manufacturer (2017-2022)
        4.1.3 Global Vaccine Conjugate Sales by Manufacturer (2017-2022)
        4.1.4 Global Vaccine Conjugate Price by Manufacturer (2017-2022)
    4.2 Global Vaccine Conjugate Concentration Ratio (CR)
        4.2.1 Vaccine Conjugate Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Vaccine Conjugate in 2021
        4.2.3 Global Vaccine Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Vaccine Conjugate Manufacturing Base Distribution, Product Type
        4.3.1 Global Vaccine Conjugate Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Vaccine Conjugate Product Type
        4.3.3 Date of International Manufacturers Enter into Vaccine Conjugate Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Vaccine Conjugate Market Size by Company
        4.5.1 Top Vaccine Conjugate Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Vaccine Conjugate Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Vaccine Conjugate Sales by Players (2020, 2021 & 2022)
5 Global Vaccine Conjugate Market Size by Region
    5.1 Global Vaccine Conjugate Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Vaccine Conjugate Market Size in Volume by Region (2017-2028)
        5.2.1 Global Vaccine Conjugate Sales in Volume by Region: 2017-2022
        5.2.2 Global Vaccine Conjugate Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Vaccine Conjugate Market Size in Value by Region (2017-2028)
        5.3.1 Global Vaccine Conjugate Sales in Value by Region: 2017-2022
        5.3.2 Global Vaccine Conjugate Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Vaccine Conjugate Market Size YoY Growth 2017-2028
        6.1.2 North America Vaccine Conjugate Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Vaccine Conjugate Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Vaccine Conjugate Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Vaccine Conjugate Market Size YoY Growth 2017-2028
        6.3.2 Europe Vaccine Conjugate Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Vaccine Conjugate Market Size YoY Growth 2017-2028
        6.4.2 Latin America Vaccine Conjugate Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Vaccine Conjugate Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Vaccine Conjugate Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporation Information
        7.1.2 Pfizer Description and Business Overview
        7.1.3 Pfizer Vaccine Conjugate Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Pfizer Vaccine Conjugate Products Offered
        7.1.5 Pfizer Recent Development
    7.2 GSK
        7.2.1 GSK Corporation Information
        7.2.2 GSK Description and Business Overview
        7.2.3 GSK Vaccine Conjugate Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 GSK Vaccine Conjugate Products Offered
        7.2.5 GSK Recent Development
    7.3 Sanofi
        7.3.1 Sanofi Corporation Information
        7.3.2 Sanofi Description and Business Overview
        7.3.3 Sanofi Vaccine Conjugate Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Sanofi Vaccine Conjugate Products Offered
        7.3.5 Sanofi Recent Development
    7.4 Merck
        7.4.1 Merck Corporation Information
        7.4.2 Merck Description and Business Overview
        7.4.3 Merck Vaccine Conjugate Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Merck Vaccine Conjugate Products Offered
        7.4.5 Merck Recent Development
    7.5 Walvax Biotechnology
        7.5.1 Walvax Biotechnology Corporation Information
        7.5.2 Walvax Biotechnology Description and Business Overview
        7.5.3 Walvax Biotechnology Vaccine Conjugate Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Walvax Biotechnology Vaccine Conjugate Products Offered
        7.5.5 Walvax Biotechnology Recent Development
    7.6 Royal (Wuxi) Bio-Pharmaceutical
        7.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
        7.6.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
        7.6.3 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Products Offered
        7.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
    7.7 Bharat Biotech
        7.7.1 Bharat Biotech Corporation Information
        7.7.2 Bharat Biotech Description and Business Overview
        7.7.3 Bharat Biotech Vaccine Conjugate Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Bharat Biotech Vaccine Conjugate Products Offered
        7.7.5 Bharat Biotech Recent Development
    7.8 Zhifei Biologic
        7.8.1 Zhifei Biologic Corporation Information
        7.8.2 Zhifei Biologic Description and Business Overview
        7.8.3 Zhifei Biologic Vaccine Conjugate Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Zhifei Biologic Vaccine Conjugate Products Offered
        7.8.5 Zhifei Biologic Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Vaccine Conjugate Industry Chain Analysis
    8.2 Vaccine Conjugate Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Vaccine Conjugate Distributors
    8.3 Vaccine Conjugate Production Mode & Process
    8.4 Vaccine Conjugate Sales and Marketing
        8.4.1 Vaccine Conjugate Sales Channels
        8.4.2 Vaccine Conjugate Distributors
    8.5 Vaccine Conjugate Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Vaccine Conjugate CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Vaccine Conjugate Market Trends
    Table 3. Vaccine Conjugate Market Drivers
    Table 4. Vaccine Conjugate Market Challenges
    Table 5. Vaccine Conjugate Market Restraints
    Table 6. Global Vaccine Conjugate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Vaccine Conjugate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Vaccine Conjugate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Vaccine Conjugate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Vaccine Conjugate Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Vaccine Conjugate Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Vaccine Conjugate Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Vaccine Conjugate Sales by Manufacturer, (K Doses), 2017-2022
    Table 14. Global Vaccine Conjugate Sales Share by Manufacturer, 2017-2022
    Table 15. Global Vaccine Conjugate Price by Manufacturer (2017-2022) & (USD/Dose)
    Table 16. Global Vaccine Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Vaccine Conjugate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Conjugate as of 2021)
    Table 18. Top Players of Vaccine Conjugate in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Vaccine Conjugate Product Type
    Table 20. Date of International Manufacturers Enter into Vaccine Conjugate Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Vaccine Conjugate Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Vaccine Conjugate Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Vaccine Conjugate Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Vaccine Conjugate Sales by Players, (K Doses), 2020, 2021 & 2022
    Table 26. United States Vaccine Conjugate Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Vaccine Conjugate Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Vaccine Conjugate Sales in Volume by Region (2017-2022) & (K Doses)
    Table 29. Global Vaccine Conjugate Sales in Volume Forecast by Region (2023-2028) & (K Doses)
    Table 30. Global Vaccine Conjugate Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Vaccine Conjugate Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Vaccine Conjugate Sales in Volume by Country (2017-2028) & (K Doses)
    Table 33. North America Vaccine Conjugate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Vaccine Conjugate Sales in Volume by Region (2017-2028) & (K Doses)
    Table 35. Asia Pacific Vaccine Conjugate Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Vaccine Conjugate Sales in Volume by Country (2017-2028) & (K Doses)
    Table 37. Europe Vaccine Conjugate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Vaccine Conjugate Sales in Volume by Country (2017-2028) & (K Doses)
    Table 39. Latin Americaa Vaccine Conjugate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Vaccine Conjugate Sales in Volume by Country (2017-2028) & (K Doses)
    Table 41. Middle East and Africa Vaccine Conjugate Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 45. Pfizer Vaccine Conjugate Product
    Table 46. Pfizer Recent Development
    Table 47. GSK Corporation Information
    Table 48. GSK Description and Business Overview
    Table 49. GSK Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 50. GSK Product
    Table 51. GSK Recent Development
    Table 52. Sanofi Corporation Information
    Table 53. Sanofi Description and Business Overview
    Table 54. Sanofi Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 55. Sanofi Product
    Table 56. Sanofi Recent Development
    Table 57. Merck Corporation Information
    Table 58. Merck Description and Business Overview
    Table 59. Merck Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 60. Merck Product
    Table 61. Merck Recent Development
    Table 62. Walvax Biotechnology Corporation Information
    Table 63. Walvax Biotechnology Description and Business Overview
    Table 64. Walvax Biotechnology Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. Walvax Biotechnology Product
    Table 66. Walvax Biotechnology Recent Development
    Table 67. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
    Table 68. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
    Table 69. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 70. Royal (Wuxi) Bio-Pharmaceutical Product
    Table 71. Royal (Wuxi) Bio-Pharmaceutical Recent Development
    Table 72. Bharat Biotech Corporation Information
    Table 73. Bharat Biotech Description and Business Overview
    Table 74. Bharat Biotech Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 75. Bharat Biotech Product
    Table 76. Bharat Biotech Recent Development
    Table 77. Zhifei Biologic Corporation Information
    Table 78. Zhifei Biologic Description and Business Overview
    Table 79. Zhifei Biologic Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 80. Zhifei Biologic Product
    Table 81. Zhifei Biologic Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Vaccine Conjugate Customers List
    Table 85. Vaccine Conjugate Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccine Conjugate Product Picture
    Figure 2. Global Vaccine Conjugate Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Vaccine Conjugate Market Size 2017-2028 (US$ Million)
    Figure 4. Global Vaccine Conjugate Sales 2017-2028 (K Doses)
    Figure 5. United States Vaccine Conjugate Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Vaccine Conjugate Market Size 2017-2028 (US$ Million)
    Figure 7. United States Vaccine Conjugate Sales 2017-2028 (K Doses)
    Figure 8. United States Vaccine Conjugate Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Vaccine Conjugate Market Share in Global, in Volume (K Doses) 2017-2028
    Figure 10. Vaccine Conjugate Report Years Considered
    Figure 11. Product Picture of Hib Vaccine
    Figure 12. Product Picture of Meningococcal Vaccine
    Figure 13. Product Picture of Pneumococcal Vaccine
    Figure 14. Product Picture of Others
    Figure 15. Global Vaccine Conjugate Market Share by Type in 2022 & 2028
    Figure 16. Global Vaccine Conjugate Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Vaccine Conjugate Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Vaccine Conjugate Sales by Type (2017-2028) & (K Doses)
    Figure 19. Global Vaccine Conjugate Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Vaccine Conjugate Price by Type (2017-2028) & (USD/Dose)
    Figure 21. United States Vaccine Conjugate Market Share by Type in 2022 & 2028
    Figure 22. United States Vaccine Conjugate Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Vaccine Conjugate Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Vaccine Conjugate Sales by Type (2017-2028) & (K Doses)
    Figure 25. United States Vaccine Conjugate Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Vaccine Conjugate Price by Type (2017-2028) & (USD/Dose)
    Figure 27. Product Picture of Children
    Figure 28. Product Picture of Adult
    Figure 29. Global Vaccine Conjugate Market Share by Application in 2022 & 2028
    Figure 30. Global Vaccine Conjugate Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Vaccine Conjugate Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Vaccine Conjugate Sales by Application (2017-2028) & (K Doses)
    Figure 33. Global Vaccine Conjugate Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Vaccine Conjugate Price by Application (2017-2028) & (USD/Dose)
    Figure 35. United States Vaccine Conjugate Market Share by Application in 2022 & 2028
    Figure 36. United States Vaccine Conjugate Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Vaccine Conjugate Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Vaccine Conjugate Sales by Application (2017-2028) & (K Doses)
    Figure 39. United States Vaccine Conjugate Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Vaccine Conjugate Price by Application (2017-2028) & (USD/Dose)
    Figure 41. North America Vaccine Conjugate Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 42. North America Vaccine Conjugate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Vaccine Conjugate Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 46. Europe Vaccine Conjugate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Vaccine Conjugate Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 53. Asia-Pacific Vaccine Conjugate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Vaccine Conjugate Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 65. Latin America Vaccine Conjugate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Vaccine Conjugate Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 70. Middle East & Africa Vaccine Conjugate Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Vaccine Conjugate Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Vaccine Conjugate Value Chain
    Figure 75. Vaccine Conjugate Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Frequently Asked Questions
Vaccine Conjugate report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vaccine Conjugate report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vaccine Conjugate report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Artificial Disc

Artificial Disc market is segmented by region (country), players, by Type and by Application. Pla ... Read More